|
Thu, 12/20/2018 - 03:42 |
LYNPARZA (olaparib) Meets Primary Endpoint in Phase 3 SOLO-3 Trial for the Treatment of Relapsed BRCA-Mutated Advanced Ovarian Cancer |
Cubist Pharmace... |
|
Wed, 12/19/2018 - 04:35 |
LYNPARZA (olaparib) Approved by FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer |
Cubist Pharmace... |
|
Tue, 12/04/2018 - 23:19 |
Genentechs Kadcyla Cut the Risk of Disease Recurring by Half Compared to Herceptin in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment |
Genentech |
|
Mon, 12/03/2018 - 07:43 |
Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test |
Exact Sciences |
|
Fri, 11/23/2018 - 14:59 |
Bold bid to beat melanoma gets $10 million boost |
QueenslandUniv |
|
Mon, 11/19/2018 - 18:41 |
Aspirin and omega-3 reduce pre-cancerous bowel polyps |
SheffieldUniv |
|
Tue, 11/13/2018 - 13:43 |
FDA grants priority review to Roches Tecentriq in combination with Abraxane for the initial treatment of people with PD-L1-positive, metastatic triple-negative breast cancer |
Rocheusa |
|
Tue, 11/13/2018 - 12:13 |
Winter Sun Safety: What to Know About Protecting Yourself During Colder Months |
Skin Cancer Fou... |
|
Tue, 11/13/2018 - 04:55 |
Connecting the genetic dots |
Van Andel |
|
Mon, 11/12/2018 - 10:37 |
FDA Grants Priority Review to Genentechs Tecentriq in Combination With Abraxane for the Initial Treatment of People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer |
Genentech |
|
Mon, 11/12/2018 - 06:07 |
FDA Accepts Regulatory Submission for LYNPARZA (olaparib) Maintenance Therapy in Newly-Diagnosed, BRCA-Mutated Advanced Ovarian Cancer and Grants Priority Review |
Merck |
|
Wed, 10/24/2018 - 09:41 |
Mount Sinai's Digital 3D Mammography Van Rolls Into New York City |
Mount Sinai |
|
Fri, 10/19/2018 - 23:42 |
Roches Tecentriq in combination with Abraxane improves outcomes as an initial treatment for people with PD-L1-positive metastatic triple-negative breast cancer |
Rocheusa |
|
Fri, 10/19/2018 - 21:22 |
Genentechs Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer |
Genentech |
|
Thu, 10/18/2018 - 17:28 |
Daiichi Sankyo Initiates Phase 1 Study of AXL Inhibitor DS-1205 in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer |
Daiichi Sankyo |
|
Mon, 10/15/2018 - 14:04 |
Brewing Up a Healthy Lifestyle: Coffee and Body Fat Reduce Liver Cancer Risk |
AICR |
|
Sun, 10/14/2018 - 17:56 |
Genentechs Kadcyla Reduced the Risk of Disease Recurring in People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment |
Genentech |
|
Wed, 10/10/2018 - 19:54 |
More than $41,000 raised for skin cancer prevention and detection through Skin Cancer, Take a Hike! - Chicago |
AAD |
|
Wed, 10/10/2018 - 09:46 |
New study finds that inflammatory proteins in the colon increase incrementally with weight |
TuftsNow |
|
Wed, 10/10/2018 - 01:54 |
Scientists Identify Genetically Accurate Mouse Models in Hepatocellular Carcinoma |
Fox Chase |
|
Thu, 10/04/2018 - 09:11 |
Breast Cancer Signs Run in the Family |
Cone Health |
|
Mon, 10/01/2018 - 12:02 |
New Cancer Statistics Strengthen Avon's Resolve To Help Educate 100 Million Women Worldwide On Breast Cancer |
Avon Products |
|
Mon, 10/01/2018 - 01:03 |
Fox Chase Cancer Center Reminds Women to Schedule a Breast Cancer Screening |
Fox Chase |
|
Sat, 09/29/2018 - 06:17 |
Memorial Sloan Kettering Announces Policy Changes |
MSKCC |
|
Thu, 09/20/2018 - 16:21 |
2nd annual skin cancer awareness walk returns to Elk Grove Village |
AAD |
